文献速递临床试验与 GCP流行病学与生物统计

VITADIAL研究:补充胆钙化醇纠正25OHD能否改善血透患者肌力?随机对照试验方案

VITADIAL "Does correction of 25 OH-VITAmin D with cholecalciferol supplementation increase muscle strength in hemoDIALysis patients?": study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-05-25

VITADIAL是一项法国多中心前瞻性开放随机对照试验,纳入25OHD≤50nmol/L的血透患者,随机接受每月100,000 UI胆钙化醇共6个月或不治疗。

要点

  • 血透患者25OHD≤50nmol/L者随机接受每月100,000 UI胆钙化醇或不予治疗,持续6个月。
  • 主要终点为基线、3和6个月时定量握力计测量的握力变化。

核心结论

  • VITADIAL试验旨在验证口服胆钙化醇补充6个月能否改善低25OHD血透患者的肌力。

研究设计与样本

  • 法国多中心前瞻性开放随机对照试验,纳入25OHD≤50nmol/L的血透患者。
  • 干预组每月口服100,000 UI胆钙化醇共6个月,对照组6个月内不治疗。
  • 补充治疗前需经3个月洗脱期(最多可重复3次,最长12个月)直至25OHD≤50nmol/L。

主要发现

  • 原文报告在130例血透患者中25OHD与握力呈独立正相关,且呈剂量依赖方式,75nmol/L以上出现平台效应。

关键数值与推荐

  • 随机化时25OHD水平≤50nmol/L为纳入标准。
  • 干预组胆钙化醇剂量为每月100,000 UI,持续6个月。
  • 主要终点为0、3、6个月时用定量握力计测量的握力。

临床怎么用

  • 该方案为血透患者补充天然维生素D改善肌力提供了随机对照试验设计框架,结果待报告。

局限性

  • 原文指出此前仅有两项随机研究分析天然维生素D对血透患者肌力的影响,但均存在把握度不足的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Muscle strength decreases as kidney failure progresses. Low muscle strength affects more than 50% of hemodialysis patients and leads to daily life activities impairment. In the general population, numerous studies have linked low 25OH-vitamin D (25OHD) concentrations to the loss of the muscle strength and low physical performances. Data on native vitamin D and muscle function are scarce in the chronic kidney disease (CKD) population, but low 25OHD levels have been associated with poor muscle strength. We present in this article the protocol of an ongoing study named VITADIAL testing if cholecalciferol supplementation in hemodialysis patients with low 25OHD improves their muscle strength. METHODS/DESIGN: VITADIAL is a prospective open randomized French multicenter study. All patients will have 25OHD levels ≤50nmol/L at randomization. One group will receive 100,000 UI cholecalciferol once a month during 6 months; the other group will receive no treatment during 6 months. In order to randomize patients with 25OHD ≤50nmol/L, supplemented patients will undergo a 3 months wash-out period renewable 3 times (maximum of 12 months wash-out) until 25OHD reaches a level ≤50nmol/L. The main objective of this study is to analyze if a 6-month period of oral cholecalciferol (i.e., native vitamin D) supplementation improves muscle strength of hemodialysis patients with low 25OHD vitamin D levels. Muscle strength will be assessed at 0, 3, and 6 months, by handgrip strength measured with a quantitative dynamometer. Secondary objectives are (1) to analyze 25OHD plasma levels after vitamin D wash-out and/or supplementation, as well as factors associated with 25OHD lowering speed during wash-out, and (2) to analyze if this supplementation improves patient's autonomy, reduces frailty risk, and improves quality of life. Fifty-four patients are needed in each group to meet our main objective. DISCUSSION: In the general population, around 30 randomized studies analyzed the effects of vitamin D supplementation on muscle strength. These studies had very different designs, sizes, and studied population. Globally, these studies and the meta-analysis of studies favor a beneficial effect of vitamin D supplementation on muscle strength, but this effect is mainly found in the subgroup of aged patients and those with the lowest 25OHD concentrations at inclusion. We reported a positive independent association between 25OHD and handgrip strength in a population of 130 hemodialysis patients in a dose-dependent manner. In our cohort, a plateau effect was observed above 75 nmol/L. Only two randomized studies analyzed the effect of native vitamin D supplementation on muscle strength in hemodialysis patients, but unfortunately, these two studies were underpowered. VITADIAL is a trial specifically designed to assess whether cholecalciferol might benefit to hemodialysis patient's muscle strength. TRIAL REGISTRATION: ClinicalTrials.gov NCT04262934 . Registered on 10 February 2020 - Retrospectively registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bataille S, Pedinielli N, Carreno E, et al. VITADIAL "Does correction of 25 OH-VITAmin D with cholecalciferol supplementation increase muscle strength in hemoDIALysis patients?": study protocol for a randomized controlled trial. Trials. 2021. PMID: 34034786. doi:10.1186/s13063-021-05302-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。